Table 3.
Baseline laboratory results and treatments of the studied 125 patients
|
|
mean ± SD/n (%)
|
| Pulse rate | 92 ± 17 |
| Temperature | 37 ± 1 |
| Respiratory rate | 23 ± 5 |
| Oxygen saturation | 93 ± 5 |
| Hemoglobin (gm/dL) | 12 ± 2 |
| Platelet count (× 1000/cmm) | 183 ± 107 |
| Total leucocyte count (× 1000/cmm) | 10 ± 8 |
| Neutrophil : Lymphocyte ratio | 1 ± 0 |
| INR | 1.16 ± 0.29 |
| PTT | 33.9 ± 13.2 |
| Serum creatinine (mg/dL) | 1.39 ± 1.43 |
| Serum sodium (mEq/L) | 137 ± 9 |
| Serum potassium (mEq/L) | 4.18 ± 0.77 |
| Total bilirubin (mg/dL) | 3 ± 5 |
| Direct bilirubin (mg/dL) | 2.1 ± 3.8 |
| Serum albumin (g/dL) | 3.2 ± 0.7 |
| Alanine Transaminase (U/L) | 58 ± 53 |
| Aspartate Transaminase (U/L) | 92 ± 123 |
| Alkaline phosphatase (U/L) | 262 ± 226 |
| Serum ferritin (ng/mL) | 667 ± 483 |
| D-dimer (mg/mL) | 1560 ± 2503 |
| Fibrinogen (mg/dL) × 100 if presented in g/L | 77 |
| Azithromycin | 72 (57.6) |
| Paracetamol | 45 (36.0) |
| Supplementary vitamin C | 85 (68.0) |
| Zinc | 69 (55.2) |
| Colchicine | 2 (1.6) |
| Lactoferrin | 18 (14.4) |
| Other antibiotics | 71 (56.8) |
| Steroids | 38 (30.4) |
| Hydroxyl-chloroquine | 29 (23.2) |
| Low-molecular weight heparin | 56 (44.8) |
| Warfarin | 3 (2.4) |
PTT: Partial thromboplastin time; INR: International normalized ratio.